Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 62 for parkinson's

Edit search filters
  1. Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease

    Jacksonville, FL

  2. Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate Zoledronic Acid for Fracture Prevention in Parkinson's Disease Patients

    Rochester, MN

  4. Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

    Scottsdale/Phoenix, AZ

  5. Functional Magnetic Resonance Imaging (fMRI) During Deep Brain Stimulation (DBS) to Treat Parkinson's Disease

    Jacksonville, FL, Rochester, MN

  6. A Study Evaluating Deep Brain Stimulation for Treating Parkinson's Patients with Insomnia

    Jacksonville, FL

  7. A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

    Scottsdale/Phoenix, AZ

  8. Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

    Scottsdale/Phoenix, AZ

  9. A Study of LY3154207 in Participants With Parkinson's Disease Dementia or Dementia with Lewy Bodies

    Scottsdale/Phoenix, AZ

  10. A Study to Evaluate the Effectiveness, Safety, and Tolerability of NLY01 in Early-stage Parkinson's Disease

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer